Xiang Yu
17Patents
4h-index
53Co-inventors
63Inventor score
Filing activity: Sep 10, 1999 → Jun 15, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7968538B2 | Substituted arylamine compounds and methods of treatment | Chemistry; Metallurgy | 16 | Active |
| US7919519B2 | S1P receptor modulating compounds and use thereof | Chemistry; Metallurgy | 13 | Active |
| US8987271B2 | 2,2′-biphenazine compounds and methods useful for treating disease | Chemistry; Metallurgy | 11 | Active |
| US7271165B2 | Rifamycin analogs and uses thereof | Chemistry; Metallurgy | 4 | Expired |
| US7547692B2 | Rifamycin analogs and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7855193B2 | S1P receptor modulating compounds and use thereof | Chemistry; Metallurgy | 3 | Active |
| US9351971B2 | Substituted 2,2′-biphenazines for treating diseases | Chemistry; Metallurgy | 3 | Active |
| US7488726B2 | Rifamycin analogs and uses thereof | Human Necessities | 2 | Active |
| US7408025B2 | Lipopeptides as antibacterial agents | Human Necessities | 2 | Expired |
| US8080542B2 | S1P receptor modulating compounds and use thereof | Chemistry; Metallurgy | 2 | Active |
| US7790707B2 | S1P receptor modulating compounds and use thereof | Human Necessities | 1 | Active |
| US6153645A | Heterocycles as antimicrobial agents | Chemistry; Metallurgy | 1 | Expired |
| US7494991B2 | Rifamycin analogs and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11001592B2 | DNA polymerase IIIC inhibitors and use thereof | Human Necessities | 0 | Active |
| US7220738B2 | Rifamycin analogs and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US10836772B2 | DNA polymerase IIIC inhibitors and use thereof | Human Necessities | 0 | Active |
| US10723741B1 | DNA polymerase IIIC inhibitors and use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.